# PROCYSBI

NDC: 75987-145
Generic name: Cysteamine bitartrate
Labeler / Manufacturer: Horizon Therapeutics USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: GRANULE, DELAYED RELEASE
Routes: ORAL
Marketing started: 20200214

FDA application: NDA213491

## Active ingredients

- CYSTEAMINE BITARTRATE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"75987-145"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=75987-145
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d3a3ec28-f746-463a-bb92-3bc8826db09e